ANIP
ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc historical holders
total: 3
Polen Capital Management ANI Pharmaceuticals Inc transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Polen Capital Management has been an institutional investor in ANI Pharmaceuticals Inc (ANIP) since 2026 Q1. According to 2026 Q1 report, Polen Capital Management holds 6,409 shares with a market value of roughly $492.85K representing 0.00% of their equity portfolio. The fund/company first acquired ANIP in 2026 Q1, initially purchasing 6,409 shares.
Does Polen Capital Management still hold ANIP?
Yes, Polen Capital Management continues to hold ANI Pharmaceuticals Inc (ANIP). According to their 2026 Q1 report, they maintain a position of 6,409 shares valued at approximately $492.85K, representing 0.00% of their equity portfolio.
When did Polen Capital Management first invest in ANIP?
Polen Capital Management first invested in ANI Pharmaceuticals Inc (ANIP) in 2026 Q1 at the reported quarter-end price of $76.90 per share, acquiring 6,409 shares in their initial purchase.
What is Polen Capital Management's average cost basis for ANIP?
Based on historical transaction data, Polen Capital Management's estimated cost basis for ANI Pharmaceuticals Inc (ANIP) is approximately $76.90 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $76.90
ANIP transactions history by Polen Capital Management
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.00%
|
6,409
|
$76.90
|
$492,852
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.